TMCAL_STAA8
ID TMCAL_STAA8 Reviewed; 379 AA.
AC Q2FZF4;
DT 11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT 21-MAR-2006, sequence version 1.
DT 03-AUG-2022, entry version 75.
DE RecName: Full=tRNA(Met) cytidine acetate ligase {ECO:0000255|HAMAP-Rule:MF_01539};
DE EC=6.3.4.- {ECO:0000255|HAMAP-Rule:MF_01539};
GN Name=tmcAL {ECO:0000255|HAMAP-Rule:MF_01539};
GN OrderedLocusNames=SAOUHSC_01076;
OS Staphylococcus aureus (strain NCTC 8325 / PS 47).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC Staphylococcus.
OX NCBI_TaxID=93061;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=NCTC 8325 / PS 47;
RA Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W., Iandolo J.J.;
RT "The Staphylococcus aureus NCTC 8325 genome.";
RL (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL Gram positive pathogens, 2nd edition, pp.381-412, ASM Press, Washington
RL D.C. (2006).
CC -!- FUNCTION: Catalyzes the formation of N(4)-acetylcytidine (ac(4)C) at
CC the wobble position of elongator tRNA(Met), using acetate and ATP as
CC substrates. First activates an acetate ion to form acetyladenylate (Ac-
CC AMP) and then transfers the acetyl group to tRNA to form ac(4)C34.
CC {ECO:0000255|HAMAP-Rule:MF_01539}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=acetate + ATP + cytidine(34) in elongator tRNA(Met) = AMP +
CC diphosphate + N(4)-acetylcytidine(34) in elongator tRNA(Met);
CC Xref=Rhea:RHEA:58144, Rhea:RHEA-COMP:10693, Rhea:RHEA-COMP:10694,
CC ChEBI:CHEBI:30089, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC ChEBI:CHEBI:74900, ChEBI:CHEBI:82748, ChEBI:CHEBI:456215;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_01539};
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01539}.
CC -!- SIMILARITY: Belongs to the TmcAL family. {ECO:0000255|HAMAP-
CC Rule:MF_01539}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000253; ABD30193.1; -; Genomic_DNA.
DR RefSeq; WP_000843611.1; NZ_LS483365.1.
DR RefSeq; YP_499622.1; NC_007795.1.
DR AlphaFoldDB; Q2FZF4; -.
DR SMR; Q2FZF4; -.
DR STRING; 1280.SAXN108_1121; -.
DR EnsemblBacteria; ABD30193; ABD30193; SAOUHSC_01076.
DR GeneID; 3919239; -.
DR KEGG; sao:SAOUHSC_01076; -.
DR PATRIC; fig|93061.5.peg.987; -.
DR eggNOG; COG1323; Bacteria.
DR HOGENOM; CLU_038915_0_2_9; -.
DR OMA; WARTKMA; -.
DR PRO; PR:Q2FZF4; -.
DR Proteomes; UP000008816; Chromosome.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0016879; F:ligase activity, forming carbon-nitrogen bonds; IEA:UniProtKB-UniRule.
DR GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR GO; GO:0006400; P:tRNA modification; IEA:UniProtKB-UniRule.
DR Gene3D; 3.40.50.620; -; 1.
DR HAMAP; MF_01539; TmcAL; 1.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR008513; tRNA(Met)_cyd_acetate_ligase.
DR PANTHER; PTHR37825; PTHR37825; 1.
DR Pfam; PF05636; HIGH_NTase1; 1.
PE 3: Inferred from homology;
KW ATP-binding; Cytoplasm; Ligase; Nucleotide-binding; Reference proteome;
KW RNA-binding; tRNA processing; tRNA-binding.
FT CHAIN 1..379
FT /note="tRNA(Met) cytidine acetate ligase"
FT /id="PRO_0000300188"
FT BINDING 7..20
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_01539"
FT BINDING 100
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_01539"
FT BINDING 153
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_01539"
FT BINDING 178
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_01539"
SQ SEQUENCE 379 AA; 43240 MW; 0ACEB045926527D4 CRC64;
MKSVGLITEY NPFHNGHQYH INQSKKLTNA DVTIAIMSGN FVMRGEPAIY NKFTRAKMAL
STADLVIELP ATASLSSGDH FAELAVKVAD YMSVDTIAFG SENNDIKTLK QLAHSINEIE
QSESFSQKVK EGKSYPRIIS ELLEHHEALA SPNNILGISY LKAIAKNAKN INAISIKREN
AQHHDSLIQH HQFASGTSIR TSIISQDDHW HHVVPKDIQH LYVTPHITLN QIFPYLKYQI
IAMTTDSLKN IYTVTEGFEN RLKSNIYEAT DFHHFVKLLK TKRYTYTHIQ RLLMNVLLNI
KPTDVTSNIH AVKVLAMNDR GRQYLKHLKT AFPERQYITN INKSNAHYFT NEIKATHIYN
AISGQQQTDF NTPVIQQYR